Cannabis Bioscience International Holdings, Inc.
CBIH
$0.0008
$0.000114.29%
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 16.48% | 145.74% | 63.58% | -29.04% | -22.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.48% | 145.74% | 63.58% | -29.04% | -22.88% |
| Cost of Revenue | -48.34% | -4.55% | -38.13% | -51.04% | 112.68% |
| Gross Profit | 36.34% | 166.41% | 117.11% | -9.23% | -35.50% |
| SG&A Expenses | -11.94% | 11.34% | -68.69% | -40.83% | -44.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.41% | 10.78% | -67.16% | -41.57% | -40.53% |
| Operating Income | 36.93% | 44.80% | 89.23% | 43.84% | 48.53% |
| Income Before Tax | 36.09% | 58.03% | 50.76% | 35.57% | 43.43% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 36.09% | 58.03% | 50.76% | 35.57% | 43.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 36.09% | 58.03% | 50.76% | 35.57% | 43.43% |
| EBIT | 36.93% | 44.80% | 89.23% | 43.84% | 48.53% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 1.60% | 1.23% | 4.94% | 31.99% | 27.70% |
| Average Diluted Shares Outstanding | 1.60% | 1.23% | 4.94% | 31.99% | 27.70% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
